Dai Ishikawa MD, Ph.D.
Chief Medical Officer
Since 2009, Dr. Ishikawa has been studying immune mechanisms and microbiota-immune relationships at the IBD Center at Case Western Reserve University in the US. In 2014, he began performing Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis (UC). Dr. Ishikawa has been an associate professor with the Faculty of Medicine at Juntendo University, Department of Gastroenterology since 2016.
Dr. Ishikawa has been working on outpatient clinic, clinical research, and research on Inflammatory Bowel Disease, including UC. He is the Principal Investigator of clinical research on FMT and is working to establish a fundamental bacteriological treatment for UC.
